Al-Olabi, L., Polubothu, S., Dowsett, K., Andrews, K. A., Stadnik, P., Joseph, A. P., . . . Keppler-Noreuil, K. M. (2018). Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. Journal of Clinical Investigation, 128(4), 1496. https://doi.org/10.1172/JCI98589
Chicago Style (17th ed.) CitationAl-Olabi, Lara, et al. "Mosaic RAS/MAPK Variants Cause Sporadic Vascular Malformations Which Respond to Targeted Therapy." Journal of Clinical Investigation 128, no. 4 (2018): 1496. https://doi.org/10.1172/JCI98589.
MLA (9th ed.) CitationAl-Olabi, Lara, et al. "Mosaic RAS/MAPK Variants Cause Sporadic Vascular Malformations Which Respond to Targeted Therapy." Journal of Clinical Investigation, vol. 128, no. 4, 2018, p. 1496, https://doi.org/10.1172/JCI98589.